Biogen Pharmachem Industries Limited

BSE:531752 Stock Report

Market Cap: ₹802.7m

Biogen Pharmachem Industries Balance Sheet Health

Financial Health criteria checks 4/6

Biogen Pharmachem Industries has a total shareholder equity of ₹553.6M and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹554.6M and ₹909.0K respectively.

Key information

0%

Debt to equity ratio

₹0

Debt

Interest coverage ration/a
Cash₹3.23m
Equity₹553.65m
Total liabilities₹909.00k
Total assets₹554.56m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 531752's short term assets (₹19.0M) exceed its short term liabilities (₹909.0K).

Long Term Liabilities: 531752 has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: 531752 is debt free.

Reducing Debt: 531752 has no debt compared to 5 years ago when its debt to equity ratio was 1.2%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if 531752 has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if 531752 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies